All Stories

  1. Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma
  2. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma
  3. External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy
  4. External validation of the H‐index (host index) in patients with head and neck squamous cell carcinomas
  5. Concordance of p16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
  6. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma
  7. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
  8. The extended SCIP flap: an anatomical and clinical study of a new SCIP flap design
  9. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC
  10. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
  11. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
  12. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy
  13. Causes of long-term mortality in patients with head and neck squamous cell carcinomas
  14. Anatomic mapping of the collateral branches of the external carotid artery with regard to daily clinical practice
  15. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors
  16. Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy
  17. Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
  18. The Effect of Perioperative Blood Transfusions on Microvascular Anastomoses
  19. The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients
  20. Oral cavity colon adenocarcinoma metastases: case report with surgical approach and review of more than 30 years literature
  21. Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV ‐negative head and neck squamous cell carcinoma patients
  22. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma
  23. Indications and results of extended total laryngectomy with en-bloc resection of overlying cervical skin
  24. The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial‐like head and neck carcinoma subtypes
  25. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status
  26. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma
  27. Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
  28. Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy
  29. Impacto de la laringectomía total en la situación laboral
  30. Prognostic value of CD45 transcriptional expression in head and neck cancer
  31. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results
  32. Validation of the pathological classification of lymph node metastasis for head and neck tumors according to the 8th edition of the TNM Classification of Malignant Tumors
  33. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma
  34. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol
  35. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study
  36. Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area
  37. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma
  38. Nodules en cavité orale, pharynx et larynx
  39. Oral cavity, pharynx and larynx nodules
  40. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer
  41. Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients
  42. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
  43. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma
  44. Management of recurrent head and neck cancer: variables related to salvage surgery
  45. Expresión de Heat Shock Protein-90 (HSP-90) como factor predictor de la respuesta a radioterapia en pacientes con tumores de cabeza y cuello
  46. Classification of parotidectomies: a proposal of the European Salivary Gland Society
  47. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
  48. External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma
  49. CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma
  50. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma
  51. Reconstrucción de defectos de cavidad oral con colgajos tipo FAMM (colgajo músculo-mucoso de arteria facial). Nuestra experiencia
  52. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients
  53. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy
  54. Tratamiento quirúrgico de los carcinomas escamosos de cabeza y cuello en España durante el periodo 2006-2011
  55. Management of Sinonasal Mucosal Melanomas and Comparison of Classification Staging Systems
  56. Parotid Incidentaloma Identified by Positron Emission/Computed Tomography: When to Consider Diagnoses Other than Warthin Tumor
  57. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy
  58. Stomal recurrence in head and neck cancer patients with temporary tracheostomy
  59. Reply to letter to the editor
  60. Etiología y tratamiento de la parálisis laríngea: estudio retrospectivo de 108 pacientes
  61. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
  62. High RAB 25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma
  63. Elective treatment of the neck for second primary tumors of the head and neck
  64. Adherencia crónica al humidificador de traqueostoma en pacientes laringectomizados
  65. Inclusion of Extracapsular Spread in the pTNM Classification System
  66. Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy
  67. Endonasal Endoscopic Scalpel-Forceps Dacryocystorhinostomy vs Endocanalicular Diode Laser Dacryocystorhinostomy
  68. Delayed carotid blow-out syndrome: a new complication of chemoradiotherapy treatment in pharyngolaryngeal carcinoma
  69. Prognostic factors in head and neck squamous cell carcinoma: Comparison of CHAID decision trees technology and cox analysis
  70. Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
  71. Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy
  72. Comparison of Chi-Squared Automatic Interaction Detection Classification Trees vs TNM Classification for Patients With Head and Neck Squamous Cell Carcinoma
  73. Second, third, and fourth head and neck tumors. A progressive decrease in survival
  74. Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2
  75. Sarcomas de cabeza y cuello. Nuestra experiencia
  76. Total or subtotal glossectomy with microsurgical reconstruction: Functional and oncological results
  77. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation
  78. Extended deep inferior epigastric artery perforator flap for head and neck reconstruction: A clinical experience with 100 patients
  79. Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy
  80. Risk of third and fourth tumors in patients with head and neck cancer
  81. Management of Sinonasal Inverted Papillomas and Comparison of Classification Staging Systems
  82. Parotidectomías en tumores benignos: clasificación «Sant Pau» de la extensión de la resección
  83. Tratamiento endoscópico combinado vs. abierto en el divertículo de Zenker
  84. Resultados de un protocolo de preservación de órgano en pacientes con tumores localmente avanzados de la laringe
  85. Ceratocricoid muscle: An embryological and anatomical study
  86. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case–control study
  87. Prostaglandin E2pathway in head and neck squamous cell carcinoma
  88. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer
  89. Colgajo de pectoral mayor
  90. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies
  91. Trasplante de la laringe: ¿una opción terapéutica para el siglo XXI? Revisión de la literatura
  92. Potential Structures That Could Be Confused With a Nonrecurrent Inferior Laryngeal Nerve: An Anatomic Study
  93. Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification
  94. Modalidades de preservación de órgano en carcinomas de laringe e hipofaringe
  95. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy
  96. Supracricoid laryngectomy as salvage surgery after failure of radiation therapy
  97. Organ Preservation in Laryngeal and Hypopharyngeal Cancer
  98. A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy
  99. Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas
  100. Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma
  101. Incidence and Significance of Clinically Unsuspected Thyroid Tissue in Lymph Nodes Found During Neck Dissection in Head and Neck Carcinoma Patients
  102. Variability in Nerve Patterns of the Adductor Muscle Group Supplied by the Recurrent Laryngeal Nerve
  103. Laryngeal cancer in non-smoking and non-drinking patients
  104. Is dissection of level V necessary in patients with T2–T4N0 supraglottic cancer?
  105. Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma
  106. Variability of the Nerve Supply Patterns of the Human Posterior Cricoarytenoid Muscle
  107. Is the External Laryngeal Nerve an Exclusively Motor Nerve? The Cricothyroid Connection Branch
  108. The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy
  109. Second Primary Tumors in Head and Neck Cancer Patients
  110. Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy
  111. Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: A therapeutic option for the no neck
  112. An anatomical study of anastomoses between the laryngeal nerves
  113. Foramen Thyroideum: A Comparative Study in Embryos, Fetuses, and Adults